Houston biopharma company CoRegen said it has received US Food and Drug Administration clearance to begin a Phase I/II trial of CRG-150, an adoptive cell therapy targeting steroid receptor coactivator ...
Medicare has expanded access to GLP-1 weight-loss medications. These drugs may also help treat addiction. Primary care ...
Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. From your friendly ...
Years ago, LSD was seen as the evil stepchild of drugs. Today, research indicates LSD may treat anxiety and depression, and ...
Phase 1/2a Clinical Trial to Evaluate Safety and Preliminary Efficacy of CRG-150 in Metastatic Triple-Negative Breast Cancer, HR+ HER2− Breast Cancer, and Prostate Cancer at Leading Academic Medical C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results